June 24, 2026
InkRoute
This is a hands-on ops problem, not a brand exercise. Phlebotomists are driving vans, juggling appointment windows, and racing specimen clocks while trying to keep labs happy. Miss a time window or a signature and the draw is wasted.
Sign up free to unlock the full analysis
Sign up to unlock
VC Panel Verdict
Marcus
The Hawk
Useful SMB B2B ops SaaS with clear ROI narrative (spoilage + rejected claims), but pricing/ARPU and assumed retention are in tension; needs proof of low-CAC channel and <12mo payback at $39–$199 tiers.
Amara
The Visionary
Textbook orchestration over infrastructure. Solves a high-stakes logistics problem with an elegant, low-cost stack. Speed-to-market is the primary weapon, and the nascent data flywheel around spoilage prediction is the long-term moat.
Sofia
The Empath
InkRoute nails the User 1 journey—phlebotomist uploads route, sees instant value in stability timers, captures signature, done. The aha moment is visceral: 'I'll never lose a sample again.' Natural word-of-mouth through lab partners who see clean PDFs. Friction exists in SMB onboarding complexity, but the core loop is viral-ready.
Market & Execution Scores
Market Sizing
- TAM (Total Addressable Market)
- $X.XB
- SAM (Serviceable Addressable Market)
- $X.XM
- SOM (Serviceable Obtainable Market)
- $X.XM
Revenue Potential
ARR Growth Projection
Year 1
$XXX,XXX
Year 2
$X.XM
Year 3 Target
$XX.XM
Pricing Tiers
X tiers
Free → Paid Conversion
XX%
Annual Retention
XX%